Search

Your search keyword '"Kala-azar -- Care and treatment"' showing total 74 results
Start Over Descriptor "Kala-azar -- Care and treatment"
74 results on '"Kala-azar -- Care and treatment"'

1. New Findings from University of Verona in the Area of Visceral Leishmaniasis Reported (Visceral Leishmaniasis Following a Plus Avd Treatment In a Patient With Classical Hodgkin's Lymphoma: a Case Report and Review of the Literature)

Subjects
Medical research, Medicine, Experimental, Lymphomas -- Care and treatment, Parasitic diseases -- Care and treatment, Kala-azar -- Care and treatment
Abstract

2024 NOV 12 (NewsRx) -- By a News Reporter-Staff News Editor at World Disease Weekly -- A new study on Parasitic Diseases and Conditions - Visceral Leishmaniasis is now available. [...]

Published
2024

2. Brazilian study identifies potential targets for treatment of visceral leishmaniasis

Subjects
Proteins, Kala-azar -- Care and treatment, Biotechnology industry, Pharmaceuticals and cosmetics industries, State University of Campinas, University of Sao Paulo
Abstract

2024 OCT 30 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Researchers at the Federal University of Sao Carlos (UFSCar), the State University of Campinas (UNICAMP) [...]

Published
2024

3. Investigators from Imperial College London Zero in on Visceral Leishmaniasis (Altered Co-stimulatory and Inhibitory Receptors On Monocyte Subsets In Patients With Visceral Leishmaniasis)

Subjects
Medical research, Medicine, Experimental, Parasitic diseases -- Care and treatment, Disease susceptibility -- Care and treatment, Kala-azar -- Care and treatment, Biological sciences, Health, University of London. Imperial College of Science and Technology, Public Library of Science
Abstract

2024 SEP 17 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- A new study on Parasitic Diseases and Conditions - Visceral Leishmaniasis is now available. [...]

Published
2024

4. Study Findings from University of Khartoum Advance Knowledge in HIV/AIDS (The Frequency of Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Co-infections among Visceral Leishmaniasis Patients and their Impact on Management)

Subjects
HIV (Viruses) -- Care and treatment, Hepatitis C virus, Infection -- Care and treatment, Hepatitis B -- Care and treatment, Hepatitis B virus -- Care and treatment, Kala-azar -- Care and treatment, Health, University of Khartoum
Abstract

2024 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Investigators publish new report on HIV/AIDS. According to news reporting out of Khartoum, Sudan, by [...]

Published
2024

5. WHO, Gilead Sciences extend collaborative pact to enhance access to treatment for visceral leishmaniasis

Subjects
Gilead Sciences Inc., Biological products industry, Public-private sector cooperation, Kala-azar -- Care and treatment, Pharmaceuticals and cosmetics industries, World Health Organization
Abstract

The World Health Organization (WHO) and Gilead Sciences have signed a new agreement for the donation of 304,700 vials of AmBisome (liposomal amphotericin B for injection), for the treatment of [...]

Published
2023

7. WHO publishes new guideline with region-specific treatment recommendations for visceral leishmaniasis in patients coinfected with HIV

Subjects
HIV (Viruses) -- Care and treatment, Virulence (Microbiology), BCG vaccines, BCG, Practice guidelines (Medicine), Comorbidity -- Care and treatment, HIV patients -- Care and treatment, Kala-azar -- Care and treatment, Pharmaceuticals and cosmetics industries, World Health Organization
Abstract

The World Health Organization (WHO) has published new treatment recommendations for visceral leishmaniasis in patients who are coinfected with the human immunodeficiency virus (HIV). The guideline targets visceral leishmaniasis in [...]

Published
2022

8. College of Natural and Computational Sciences Researchers Highlight Research in HIV/AIDS (Time to death and its determinant factors of visceral leishmaniasis with HIV co-infected patients during treatment period admitted at Metema hospital, ...)

Subjects
HIV (Viruses) -- Care and treatment, HIV patients -- Care and treatment, Kala-azar -- Care and treatment, Health
Abstract

2023 NOV 13 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- A new study on HIV/AIDS is now available. According to news reporting from the College [...]

Published
2023

9. Switzerland : WHO and Gilead Sciences extend collaborative agreement to enhance access to treatment for visceral leishmaniasis

Subjects
Gilead Sciences Inc., Biological products industry, Public-private sector cooperation, Kala-azar -- Care and treatment, Business, international, World Health Organization
Abstract

The World Health Organization (WHO) and Gilead Sciences have signed a new agreement for the donation of 304,700 vials of AmBisome (liposomal amphotericin B for injection), for the treatment of [...]

Published
2023

10. WHO and Gilead Sciences to enhance access to treatment for visceral leishmaniasis

Subjects
Gilead Sciences Inc., Biological products industry, Kala-azar -- Care and treatment, Biotechnology industry
Abstract

Donated medicines and funding support will benefit the expansion and strengthening of leishmaniasis surveillance and control The World Health Organisation (WHO) and US-based biopharmaceutical firm Gilead Sciences have signed a [...]

Published
2023

11. WHO and Gilead Sciences Extend Collaborative Agreement to Enhance Access to Treatment for Visceral Leishmaniasis

Subjects
Gilead Sciences Inc., Biological products industry, Public-private sector cooperation, Kala-azar -- Care and treatment, News, opinion and commentary, World Health Organization
Abstract

The World Health Organization (WHO) and Gilead Sciences have signed a new agreement for the donation of 304,700 vials of AmBisome (liposomal amphotericin B for injection), for the treatment of [...]

Published
2023

12. Findings on Visceral Leishmaniasis Reported by Investigators at Indian Council for Medical Research (Transcriptome Analysis of Dermal Fibroblasts Derived From Visceral Leishmaniasis and Post-kala-azar Dermal Leishmaniasis Patients Reveal ...)

Subjects
Medical research -- Analysis, Medicine, Experimental -- Analysis, RNA sequencing -- Analysis, Parasitic diseases -- Care and treatment, Kala-azar -- Care and treatment, Biological sciences, Health
Abstract

2023 APR 25 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Current study results on Parasitic Diseases and Conditions - Visceral Leishmaniasis have been published. [...]

Published
2023

13. Visceral Leishmaniasis and HIV Coinfection - WHO Publishes New Guideline With Region-Specific Treatment Recommendations

Subjects
HIV (Viruses) -- Care and treatment, Virulence (Microbiology), BCG vaccines, BCG, Practice guidelines (Medicine), Comorbidity -- Care and treatment, Kala-azar -- Care and treatment, News, opinion and commentary, World Health Organization
Abstract

The World Health Organization (WHO) has published new treatment recommendations for visceral leishmaniasis in patients who are coinfected with the human immunodeficiency virus (HIV). The guideline targets visceral leishmaniasis in [...]

Published
2022

14. Switzerland : Visceral leishmaniasis and HIV coinfection: WHO publishes new guideline with region-specific treatment recommendations

Subjects
HIV (Viruses) -- Care and treatment, Virulence (Microbiology), Practice guidelines (Medicine), Comorbidity -- Care and treatment, Kala-azar -- Care and treatment, Business, international, World Health Organization
Abstract

The World Health Organization (WHO) has published new treatment recommendations for visceral leishmaniasis in patients who are coinfected with the human immunodeficiency virus (HIV). The guideline targets visceral leishmaniasis in [...]

Published
2022

15. Reports from Imperial College London Provide New Insights into Visceral Leishmaniasis (Impaired In Vitro Interferon-gamma Production In Patients With Visceral Leishmaniasis Is Improved By Inhibition of Pd1/pdl-1 Ligation)

Subjects
Interferon, Medical research, Medicine, Experimental, Parasitic diseases -- Care and treatment, Biological response modifiers, Kala-azar -- Care and treatment, Health, University of London. Imperial College of Science and Technology, Public Library of Science, Wellcome Trust
Abstract

2022 SEP 13 (NewsRx) -- By a News Reporter-Staff News Editor at World Disease Weekly -- A new study on Parasitic Diseases and Conditions - Visceral Leishmaniasis is now available. [...]

Published
2022

16. Leishmanicidal activity assessment of olive tree extracts

Author

Kyriazis, Joannis D., Aligiannis, Nektarios, Polychronopoulos, Panagiotis, Skaltsounis, Alexios-Leandros, and Dotsika, Eleni

Subjects
Materia medica, Vegetable -- Usage, Medicine, Botanic -- Research, Olive -- Health aspects -- Usage, Medicine, Herbal -- Research, Kala-azar -- Care and treatment, Plant extracts -- Usage, Biological sciences, Health, Science and technology
Abstract

ARTICLE INFO Keywords: Natural products Oleuropein Hydroxytyrosol Visceral leishmaniasis ABSTRACT Leishmaniasis, a protozoan parasitic disease that remains a major worldwide health problem with high endemicity in developing countries, is prevalent [...]

Published
2013

18. Combination therapy for visceral leishmaniasis

Author

Van Griensven, Johan, Balasegaram, Manica, Meheus, Filip, Alvar, Jorge, Lynen, Lutgarde, and Boelaert, Marleen

Subjects
Drug resistance -- Care and treatment, Kala-azar -- Care and treatment, Public health
Published
2010

19. Single-dose liposomal amphotericin B for visceral leishmaniasis in India

Author

Sundar, Shyam, Chakravarty, Jaya, Agarwal, Dipti, Rai, Madhukar, and Murray, Henry W.

Subjects
Amphotericin B -- Comparative analysis, Amphotericin B -- Usage, Amphotericin B -- Health aspects, Parenteral feeding -- Usage, Parenteral feeding -- Health aspects, Parenteral feeding -- Comparative analysis, Parenteral therapy -- Usage, Parenteral therapy -- Health aspects, Parenteral therapy -- Comparative analysis, Kala-azar -- Care and treatment, Bihar, India (State) -- Health aspects
Abstract

A study was conducted to evaluate and compare the efficacy of a single dose of liposomal amphotericin B as against conventional parenteral therapy of 15 alternate day infusion for patients with visceral leishmaniasis in the state of Bihar, India. Results indicated that a single-dose was equally effective as a 15 alternative day treatment and also less expensive.

Published
2010

24. Medecins Sans Frontieres Reports Findings in HIV/AIDS (AmBisome monotherapy and combination AmBisome - miltefosine therapy for the treatment of visceral leishmaniasis in patients co-infected with HIV in India: a randomised open label, parallel ...)

Subjects
Oxford University Press (Oxford, England), HIV (Viruses) -- Care and treatment, Medical research, Medicine, Experimental, Book publishing, HIV patients -- Care and treatment, Labels, Periodical publishing, Kala-azar -- Care and treatment, General interest
Abstract

2022 FEB 22 (VerticalNews) -- By a News Reporter-Staff News Editor at Journal of India -- New research on Immune System Diseases and Conditions - HIV/AIDS is the subject of [...]

Published
2022

25. Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors

Author

Trudel, Nathalie, Garg, Ravendra, Messier, Nadine, Sundar, Shyam, Ouellette, Marc, and Tremblay, Michel J.

Subjects
Protease inhibitors -- Dosage and administration, Protease inhibitors -- Research, Kala-azar -- Care and treatment, Kala-azar -- Research, HIV infection -- Care and treatment, Comorbidity -- Management, Company business management, Health
Published
2008

26. First Affiliated Hospital of Xi'an Jiaotong University Researchers Provide New Data on Liposomes (Case Report: Use of Liposomal Amphotericin B in Low Doses in Patients With Visceral Leishmaniasis)

Subjects
Antiparasitic agents -- Usage, Amphotericin B -- Usage, Kala-azar -- Care and treatment, Health
Abstract

2021 NOV 29 (NewsRx) -- By a News Reporter-Staff News Editor at Malaria Weekly -- New research on liposomes is the subject of a new report. According to news reporting [...]

Published
2021

28. Researchers from University of Sao Paulo Report Details of New Studies and Findings in the Area of Visceral Leishmaniasis (Serum Antibodies Blocked By Glycan Antigens In Canine Visceral Leishmaniasis Serology Are Mostly Iga Immune Complexes)

Subjects
Immune response -- Research, Antigens -- Research, Enzyme-linked immunosorbent assay -- Research, Dogs -- Health aspects, Kala-azar -- Care and treatment, Biological sciences, Health
Abstract

2021 OCT 5 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Current study results on Parasitic Diseases and Conditions - Visceral Leishmaniasis have been published. [...]

Published
2021

29. Comparative evaluation of aqueous and freeze dried antigen for sero-diagnosis of VL and PKDL cases by DAT

Author

Bimal, Sanjiva, Singh, Shubhankar K., Sinha, P.K., Das, P.K., Schallig, H., Das, P., and Bhattacharya, S.K.

Subjects
Kala-azar -- Care and treatment, Kala-azar -- Research, Antigens -- Storage, Agglutination tests -- Usage, Biological sciences
Abstract

Abstract: The efficacy of aqueous and freeze dried (FD) antigen was evaluated by direct agglutination test (DAT) for sero-diagnosis of visceral leishmaniasis. A total of 16 samples collected from 5 [...]

Published
2005

33. Antigen genes for molecular epidemiology of leishmaniasis: polymorphism of cysteine proteinase B and surface metalloprotease glycoprotein 63 in the Leishmania donovani complex

Author

Quispe Tintaya, Kelly Wilber, Ying, Xu, Dedet, Jean-Pierre, Rijal, Suman, De Bolle, Xavier, and Dujardin, Jean-Claude

Subjects
Kala-azar -- Care and treatment, Kala-azar -- Research, Genetic polymorphisms -- Research, Cysteine proteinases -- Health aspects, Cysteine proteinases -- Research, Health
Published
2004

34. Novel mechanism of drug resistance in kala azar field isolates

Author

Singh, Neeloo, Singh, Ramsing Th., and Sundar, Shyam

Subjects
Proteins -- Physiological aspects, Proteins -- Genetic aspects, Phosphorylation -- Physiological aspects, Kala-azar -- Health aspects, Kala-azar -- Care and treatment, Kala-azar -- Demographic aspects, Kala-azar -- Genetic aspects, Gene mutations -- Physiological aspects, Drug resistance -- Physiological aspects, Drug resistance -- Health aspects, Drug resistance -- Causes of, Patients -- Health aspects, Patients -- Care and treatment, Patients -- Demographic aspects, Airborne infection -- Research, Airborne infection -- Causes of, Health
Published
2003

35. Determinants of response to interleukin-10 Receptor blockade immunotherapy in experimental visceral leishmaniasis

Author

Murray, Henry W., Moreira, Andre L., Lu, Cristina M., DeVecchio, Jennifer L., Matsuhashi, Maki, Ma, Xiaojing, and Heinzel, Frederick P.

Subjects
Interleukins -- Physiological aspects, Gene expression -- Physiological aspects, Nitric oxide -- Physiological aspects, Proteins -- Physiological aspects, Kala-azar -- Causes of, Kala-azar -- Health aspects, Kala-azar -- Care and treatment, Kala-azar -- Prevention, Viral antibodies -- Physiological aspects, Viral antibodies -- Genetic aspects, Antibodies -- Physiological aspects, Antibodies -- Genetic aspects, Airborne infection -- Research, Airborne infection -- Causes of, Health
Published
2003

36. Recent understanding in the treatment of visceral leishmaniasis

Author

Rosenthal, E and Marty, P

Subjects
World Health Organization -- Reports, Kala-azar -- Health aspects, Kala-azar -- Care and treatment, Kala-azar -- Causes of, Kala-azar -- Prevention, Developing countries -- Health aspects, Amphotericin B -- Physiological aspects, Amphotericin B -- Dosage and administration, Drug resistance -- Health aspects, Drug resistance -- Physiological aspects, HIV (Viruses) -- Prevention, HIV (Viruses) -- Health aspects, HIV (Viruses) -- Care and treatment, HIV (Viruses) -- Complications, Medical students -- Tests, problems and exercises, Postdoctoral education -- Tests, problems and exercises, Physical diagnosis -- Practice, Physical diagnosis -- Analysis, Periodic health examinations -- Practice, Periodic health examinations -- Analysis, HIV patients -- Health aspects, HIV patients -- Care and treatment, HIV patients -- Drug therapy, Clinical medicine -- Research
Abstract

Abstract: Visceral leishmaniasis (VL) is a severe disease associated with infection of the reticuloendothelial system by Leishmania species. The infection is acquired through sandfly bites. Recent large scale epidemics of [...]

Published
2003

37. An Overview of Paediatric leishmaniasis

Author

Kafetzis, Dimitris A.

Subjects
Amphotericin B -- Physiological aspects, Kala-azar -- Health aspects, Kala-azar -- Care and treatment, Kala-azar -- Causes of, Kala-azar -- Prevention, Postdoctoral education -- Tests, problems and exercises, Sick children -- Health aspects, Sick children -- Care and treatment, Sick children -- Demographic aspects, Clinical medicine -- Research
Abstract

Abstract: Leishmaniasis, a parasitic disease transmitted by the bite of some species of sandflies affects various age groups depending on the infecting Leishmania species, geographic location, disease reservoir, and host [...]

Published
2003

38. Studies from Antoni Van Leeuwenhoek Hospital Provide New Data on Visceral Leishmaniasis (Geographical Variability In Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences Between Eastern African and Indian Visceral Leishmaniasis ...)

Subjects
Medical research, Medicine, Experimental, Parasitic diseases -- Care and treatment, Kala-azar -- Care and treatment, Health
Abstract

2021 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at World Disease Weekly -- A new study on Parasitic Diseases and Conditions - Visceral Leishmaniasis is now available. [...]

Published
2021

40. Laboratory of Pathology Researchers Advance Knowledge in Visceral Leishmaniasis (Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis)

Subjects
Medical research, Medicine, Experimental, Terpenes -- Research, Kala-azar -- Care and treatment, Biological sciences, Health
Abstract

2021 MAR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Investigators publish new report on visceral leishmaniasis. According to news reporting from the Laboratory [...]

Published
2021

41. Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004

Author

Malik, Aeesha N.J., John, Lawrence, Bryceson, Anthony D.M., and Lockwood, Diana N.J.

Subjects
Kala-azar -- Causes of, Kala-azar -- Care and treatment, Kala-azar -- Diagnosis
Abstract

A 20-year (1985-2004) retrospective review of 39 patients with imported visceral leishmaniasis found that tourism to Mediterranean countries and HIV infection were associated with visceral leishmaniasis. Diagnosis was often delayed. [...]

Published
2006

42. Studies from Saint-Louis Hospital in the Area of Visceral Leishmaniasis Reported (Visceral Leishmaniasis In Patients With Lymphoma Case Reports and Review of the Literature)

Subjects
Medical research, Medicine, Experimental, Diseases -- Care and treatment -- France, Lymphomas -- Care and treatment, Parasitic diseases -- Care and treatment, Kala-azar -- Care and treatment, Bendamustine, Health
Abstract

2020 DEC 21 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Researchers detail new data in Parasitic Diseases and Conditions - Visceral Leishmaniasis. According to news [...]

Published
2020

43. Research Reports on Visceral Leishmaniasis from Federal University Ouro Preto Provide New Insights [Phase I and II Clinical Trial Comparing the LBSap, Leishmune[superscript]®, and Leish-Tec[superscript]® Vaccines against Canine Visceral Leishmanias

Subjects
Immunology -- Analysis, Vaccines -- Testing, Kala-azar -- Care and treatment, Biological sciences, Health
Abstract

2020 DEC 1 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Fresh data on visceral leishmaniasis are presented in a new report. According to news [...]

Published
2020

44. Visceral leishmaniasis: clinical observations in 4 US army soldiers deployed to Afghanistan or Iraq, 2002-2004

Author

Myles, Otha, Wortmann, Glenn W., Cummings, James F., Barthel, R. Vincent, Patel, Sugat, Crum-Cianflone, Nancy F., Negin, Nathan S., Weina, Peter J., Ockenhouse, Christian F., Joyce, Daniel J., Magill, Alan J., Aronson, Naomi E., and Gasser, Robert A., Jr.

Subjects
Kala-azar -- Development and progression, Kala-azar -- Care and treatment, Kala-azar -- Patient outcomes, Kala-azar -- Research, Deployment (Strategy) -- Health aspects, Military personnel -- Health aspects, Health
Published
2007

45. Miltefosine: great expectations against visceral leishmaniasis

Author

More, B, Bhatt, H, Kukreja, V, and Ainapure, SS

Subjects
Antineoplastic agents -- Physiological aspects, Antimitotic agents -- Physiological aspects, Therapeutics -- Physiological aspects, Therapeutics -- Health aspects, T cells -- Physiological aspects, Cytokines -- Physiological aspects, Interferon -- Physiological aspects, Ethers -- Physiological aspects, Phospholipids -- Physiological aspects, Pharmacokinetics -- Research, Kala-azar -- Health aspects, Kala-azar -- Care and treatment, Postdoctoral education -- Tests, problems and exercises, Diagnosis -- Analysis, Physical diagnosis -- Practice, Physical diagnosis -- Analysis, Periodic health examinations -- Practice, Periodic health examinations -- Analysis, Patients -- Health aspects, Patients -- Care and treatment, Patients -- Drug therapy, Clinical medicine -- Research
Abstract

Visceral leishmaniasis is a disease endemic in 47 countries and continues to be a difficult therapeutic challenge. (1) There are an estimated 500 000 cases per year in Asia (primarily [...]

Published
2003

46. Visceral leishmaniasis in India

Author

Bryceson, Anthony

Subjects
Kala-azar -- Care and treatment, Amphotericin B -- Dosage and administration, India -- Health aspects
Published
2000

47. Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis

Author

Boelaert, M., Lynen, L., Desjeux, P., and Van der Stuyft, P.

Subjects
Kala-azar -- Care and treatment, Medical care, Cost of -- Economic aspects
Abstract

Reported are the results of a formal decision analysis which facilitated the choice of the most appropriate test-treatment strategy for visceral leishmaniasis in areas where the disease is endemic. The following strategies were compared: treatment of all suspects (strategy A); testing by means of parasitological investigation followed by treatment of positives (strategy B); two-step testing by means of the direct agglutination test (DAT) followed by treatment of patients with high titres as well as those with parasitologically confirmed borderline titres (strategy C); and DAT followed by treatment of positives (strategy D). The results for each strategy were expressed as costs in US$ per death averted. The effectiveness of strategies C and D was close to that of strategy A and far better than that of strategy B. The cost-effectiveness ratio for strategies C and D (US$ 465 per death averted) was not substantially higher than that of testing by means of parasitological investigation followed by treatment of positives (strategy B), which was the most cost-effective strategy at US$448 per death averted. At current prices of antimonial drugs, the cost of test-treatment strategies depends more on the cost of treatment than on that of testing. The use of a sensitive serological test such as the DAT is recommended as the basis of test-treatment strategies for visceral leishmaniasis in areas where the disease is endemic., Voir page 672 le resume en francais. En la pagina 673 figura un resumen en espanol. Introduction Visceral leishmaniasis, a protozoal disease estimated to cause 414 000 new cases annually [...]

Published
1999

48. Visceral leishmaniasis mimicking lymphoproliferative disease

Author

Kaziani, Katerina, Vadala, Chariclea, Stasinopoulou, Panagiota, Loverdos, Dionysios, Samarkos, Michael, and Skoutelis, Athanasios

Subjects
Kala-azar -- Risk factors, Kala-azar -- Diagnosis, Kala-azar -- Care and treatment, Kala-azar -- Case studies, Health
Published
2010

49. Drug dependents

Author

mirasol, feliza

Subjects
Communicable diseases -- Care and treatment, Drugs -- Health aspects, Pharmaceutical industry -- Licensing, certification and accreditation, Kala-azar -- Care and treatment, Business, Business, international, Chemicals, plastics and rubber industries
Abstract

A huge push by pharmaceutical companies and charities is boosting availability of drugs in developing nations. Yet poor healthcare infrastructure remains a major challenge Medicines must be affordable and accessible [...]

Published
2008

50. Visceral Leishmaniasis in 4 US Army Soldiers

Subjects
United States. Army, Kala-azar -- Diagnosis, Kala-azar -- Care and treatment, Antiparasitic agents, Soldiers, Amphotericin B, Armies, Health
Abstract

Visceral Leishmaniasis in 4 US Army Soldiers Abstract and Commentary By Dean L. Winslow, MD, FACP, FIDSA, Chief, Division of AIDS Medicine, Santa Clara Valley Medical Center; Clinical Professor, Stanford [...]

Published
2008

Catalog

Books, media, physical & digital resources
See catalog results